- Axe aims for world peace with Axe Peace, campaign
- Intel survey: Patients ready to embrace personalized medicine
- Insurance rollout shows pharmacies and NACDS in action
- Report: 'Shark Tank' proves successful for Breathometer
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
SAN ANTONIO — Mission Pharmacal Co. on Tuesday announced its “ABCs of Medical Management of Stones,” a step-by-step approach to the diagnosis and treatment of nephrolithiasis, or kidney stones, is now available as a mobile application for Apple devices.
“The ABCs of Kidney Stones app may simplify an otherwise complicated diagnosis, guiding the physician through the process using a standard protocol that differentiates between first-time and recurrent stone formers,” stated Dan Crawford, marketing director of the Urological Division of Mission Pharmacal Company. “The app provides an interactive and updated version of the popular ABCs literature, which was developed and co-authored by some of the most respected and recognized thought leaders in the management of kidney stones. Their reputations alone add tremendous credibility to this app.”
The ABCs of Medical Management of Stones, now in its second edition, was recently updated by co-authors Margaret Pearle, Glenn Preminger, David Goldfarb and Donald Griffith, with additional input from Charles Pak, for physicians who were looking for an efficient way to manage the complexities of stone disease. “First with the booklet, and now with the app, the ABCs make the doctors’ job easier. The app will get the ABCs into the hands and pockets of younger physicians or those who prefer to get information electronically,” Crawford said.
The app also will allow physicians to show videos to their patients during a visit with topics including how a kidney stone is formed.
The ABCs of Medical Management of Stones was initially released on iTunes for use on Apple devices because at least 60% of physicians now use an iPad tablet in their practices.
The app will be released for use on an Android platform in coming months.